QEQ278
CQEQ278A12101
Phase 1 mab terminated
Quick answer
QEQ278 for Carcinoma, Non-Small-Cell Lung is a Phase 1 program (mab) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Pharmaceuticals
- Indication
- Carcinoma, Non-Small-Cell Lung
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated